Noradrenergic system

The noradrenergic system refers to an entire neurotransmitter system in the brain and body that uses **noradrenaline (norepinephrine)** as its primary neurotransmitter[1][7][6]. The core source of noradrenergic innervation in the brain is the **locus coeruleus**, with additional minor sources in other brainstem nuclei[7][6]. Noradrenaline is released by highly branched axons and exerts neuromodulatory actions throughout the central nervous system by acting on **adrenergic receptors** (including α1, α2, β1, β2, β3 types)[1][3][7]. These are all G protein-coupled receptors, distributed on both neurons and glial cells, and mediate diverse actions such as arousal, learning, attention, and pain modulation[3][7][6]. The noradrenergic system is not a single molecular entity (i.e., not a receptor, enzyme, or ion channel), but an anatomical and functional pathway encompassing many molecular targets (transporters, receptors, synthetic enzymes, degradation enzymes, etc.)[7][6]. As such, it is not considered a canonical "therapeutic target" in the molecular sense; instead, drugs affect components of the system such as adrenergic receptors (e.g., α2-adrenergic receptor), the noradrenaline transporter, or synthesis enzymes[7][1][4]. In summary, the noradrenergic system is a complex, distributed network and does not correspond to a single molecular target. For drug discovery or structured target curation, one must specify a distinct protein or molecular target (e.g., "β2-adrenergic receptor" or "norepinephrine transporter"), not the system as a whole[7][1][4]. Caveat: This entry is flagged as "is_incorrect: true" because "Noradrenergic system" is not a single, specific molecular target, but a broad neurotransmitter system consisting of various molecular components.

Other names

Noradrenaline systemNorepinephrine systemNA system